These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34469345)
21. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. Malka D; Cervera P; Foulon S; Trarbach T; de la Fouchardière C; Boucher E; Fartoux L; Faivre S; Blanc JF; Viret F; Assenat E; Seufferlein T; Herrmann T; Grenier J; Hammel P; Dollinger M; André T; Hahn P; Heinemann V; Rousseau V; Ducreux M; Pignon JP; Wendum D; Rosmorduc O; Greten TF; Lancet Oncol; 2014 Jul; 15(8):819-28. PubMed ID: 24852116 [TBL] [Abstract][Full Text] [Related]
22. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial. Sahai V; Catalano PJ; Zalupski MM; Lubner SJ; Menge MR; Nimeiri HS; Munshi HG; Benson AB; O'Dwyer PJ JAMA Oncol; 2018 Dec; 4(12):1707-1712. PubMed ID: 30178032 [TBL] [Abstract][Full Text] [Related]
23. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839 [TBL] [Abstract][Full Text] [Related]
24. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin. Martin RCG; Simo KA; Hansen P; Rocha F; Philips P; McMasters KM; Tatum CM; Kelly LR; Driscoll M; Sharma VR; Crocenzi TS; Scoggins CR Ann Surg Oncol; 2022 Sep; 29(9):5462-5473. PubMed ID: 35657463 [TBL] [Abstract][Full Text] [Related]
25. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin. Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632 [TBL] [Abstract][Full Text] [Related]
28. [Surgical Resection after Gemcitabine plus Cisplatin Chemotherapy for Intrahepatic Cholangiocarcinoma with Multiple Lymph Node Metastases - Report of a Case]. Otani T; Sakata J; Kameyama H; Otani A; Hirose Y; Tamura H; Morimoto Y; Miura K; Yoshino K; Kido T; Kobayashi T; Endo K; Wakai T Gan To Kagaku Ryoho; 2016 Nov; 43(12):1764-1766. PubMed ID: 28133124 [TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392 [TBL] [Abstract][Full Text] [Related]
30. Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery. Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Nakadai E; Kishimoto T; Nakatani Y; Yoshidome H; Miyazaki M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1093-9. PubMed ID: 26240009 [TBL] [Abstract][Full Text] [Related]
31. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. Shroff RT; Javle MM; Xiao L; Kaseb AO; Varadhachary GR; Wolff RA; Raghav KPS; Iwasaki M; Masci P; Ramanathan RK; Ahn DH; Bekaii-Saab TS; Borad MJ JAMA Oncol; 2019 Jun; 5(6):824-830. PubMed ID: 30998813 [TBL] [Abstract][Full Text] [Related]
32. [A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1]. Ogura N; Hoshino M; Hayashi T; Odaira M; Harada H; Hirose S; Funakoshi S Gan To Kagaku Ryoho; 2022 Dec; 49(13):1665-1667. PubMed ID: 36733169 [TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of palliative chemotherapy in inoperable cholangiocarcinoma in Thailand. Butthongkomvong K; Sirachainan E; Jhankumpha S; Kumdang S; Sukhontharot OU Asian Pac J Cancer Prev; 2013; 14(6):3565-8. PubMed ID: 23886146 [TBL] [Abstract][Full Text] [Related]
34. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Meyerhardt JA; Zhu AX; Stuart K; Ryan DP; Blaszkowsky L; Lehman N; Earle CC; Kulke MH; Bhargava P; Fuchs CS Dig Dis Sci; 2008 Feb; 53(2):564-70. PubMed ID: 17597402 [TBL] [Abstract][Full Text] [Related]
35. Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma. Ishii M; Itano O; Morinaga J; Shirakawa H; Itano S PLoS One; 2022; 17(4):e0266707. PubMed ID: 35452492 [TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma. Ni JY; Sun HL; Guo GF; Zhou X; Wei JX; Xu LF Int Immunopharmacol; 2024 Oct; 140():112872. PubMed ID: 39121605 [TBL] [Abstract][Full Text] [Related]
38. [A case of unresectable hilar cholangiocarcinoma successfully treated by gemcitabine and S-1 combination chemotherapy]. Tada S; Fujikawa T; Tanaka A; Abe T; Yoshimoto Y; Maekawa H; Shimoike N; Tanaka H; Kawashima T; Shiraishi K Gan To Kagaku Ryoho; 2012 Aug; 39(8):1279-82. PubMed ID: 22902459 [TBL] [Abstract][Full Text] [Related]
39. [A Case of Liver Metastasis of Intrahepatic Cholangiocarcinoma That Achieved Clinical Complete Response after Gemcitabine and Cisplatin Combination Chemotherapy]. Kim Y; Hata T; Tanizaki K; Okano M; Kawada J; Okuyama M; Yamasaki M; Murakami M; Shimizu J; Miwa H; Imamoto H; Tsujinaka T Gan To Kagaku Ryoho; 2019 Feb; 46(2):360-362. PubMed ID: 30914560 [TBL] [Abstract][Full Text] [Related]
40. [A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy]. Nishizawa T; Higuchi H; Takaishi H; Iizuka H; Izumiya M; Yamagishi Y; Hisamatsu T; Suzuki H; Masaoka T; Iwasaki E; Nagata H; Hibi T Gan To Kagaku Ryoho; 2006 Nov; 33(11):1657-9. PubMed ID: 17108736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]